Medically Reviewed by Dr. Kathleen Valenton, Board-Certified OB/GYN | 5 min read | Published: April 2026

Akkermansia muciniphila has been the subject of over 1,000 published scientific studies1 and the research connecting it to metabolic health is compelling. But what does the science actually show? Here’s an honest, evidence-based look at what we know about Akkermansia and metabolism, and why researchers are so excited about this gut bacterium — and why Akkermansia supplements are gaining attention.


TL;DR

  • Akkermansia is strongly linked to metabolic health and gut barrier function

  • Lower levels are consistently associated with metabolic challenges

  • It may support insulin sensitivity, GLP-1 signaling, and weight maintenance

  • Pasteurized Akkermansia (MucT®) is the most clinically studied form

  • Research is promising but still evolving


Akkermansia benefits for metabolism: key findings

  • Associated with improved insulin sensitivity

  • Supports gut barrier integrity

  • Linked to GLP-1 signaling pathways

  • Plays a role in weight maintenance after weight loss


What is Akkermansia muciniphila?

Akkermansia muciniphila is a beneficial gut bacterium that lives in the intestinal lining and supports gut barrier function, metabolism, and immune health.


The Gut Microbiome-Metabolism Connection

Your gut microbiome — the trillions of bacteria living in your digestive tract — plays a far bigger role in metabolic health than scientists once realized. These microbes influence how your body processes food, stores fat, regulates blood sugar, and even manages appetite signals. Among the hundreds of bacterial species that make up your microbiome, Akkermansia muciniphila has emerged as one of the most metabolically significant.*


Akkermansia and metabolic health: what research shows

Multiple studies have observed that people with metabolic challenges, including those managing weight, blood sugar, and energy, tend to have significantly lower levels of Akkermansia in their gut microbiome compared to metabolically healthy individuals.2* This correlation has been replicated across multiple independent research groups and populations, making it one of the more consistent findings in microbiome science.*

Notably, research published in peer-reviewed journals has found that Akkermansia levels can decline due to factors many people encounter daily, including a diet low in fiber and polyphenols, antibiotic use, aging, and chronic stress.3* Given how common these factors are, it’s perhaps unsurprising that Akkermansia deficiency appears to be widespread.


Akkermansia and Gut Barrier Integrity

One of the primary mechanisms through which Akkermansia influences metabolism is gut barrier health.* Akkermansia lives in the mucus layer of the intestinal wall and stimulates the body to produce more mucin, the protein that forms the gut’s protective lining.4* A stronger gut barrier helps prevent the passage of harmful substances into the bloodstream — a condition sometimes referred to as “leaky gut” — which has been linked to systemic inflammation and disrupted metabolic function.4*

When the gut barrier is compromised, the resulting inflammatory response can interfere with the body’s ability to regulate fat storage, blood sugar, and energy balance.5* By supporting gut barrier integrity, Akkermansia may help address one of the root causes of metabolic disruption at the microbiome level.*


Akkermansia and GLP-1

One of the more exciting areas of Akkermansia research involves GLP-1 — glucagon-like peptide-1 — the hormone that helps regulate appetite, blood sugar, and feelings of fullness. GLP-1 has become a major focus of metabolic health research, with pharmaceutical GLP-1 agonists now widely prescribed for weight management.

Preclinical research suggests that Akkermansia may support the body’s natural production of GLP-1 by strengthening the gut lining and influencing the gut-brain signaling axis.6* While this research is still developing and most evidence comes from preclinical studies, the connection between Akkermansia, gut barrier health, and GLP-1 signaling is an active and promising area of investigation.*


Akkermansia and Weight Maintenance After Weight Loss

Perhaps most relevant for anyone on a metabolic health journey is the research linking Akkermansia to weight maintenance after weight loss. Studies suggest that individuals who successfully maintain weight loss tend to have higher levels of Akkermansia in their microbiome compared to those who regain weight.7* Researchers have proposed that Akkermansia’s role in gut barrier function and metabolic signaling may help the body sustain the metabolic improvements achieved through diet and lifestyle changes.*

This is why weight maintenance — after weight loss — has become a key focus of Akkermansia research, and why it’s the primary claim supported by the most robust human clinical data on the strain.*


Pasteurized Akkermansia: The Research-Backed Form

When choosing an Akkermansia supplement, the form and strain matter. Not all Akkermansia supplements deliver the strain in a form that the research supports. The most extensively studied form is pasteurized Akkermansia muciniphila — specifically the MucT® strain developed by The Akkermansia Company, the team of scientists who first identified and decoded the bacterium. Their human clinical trials demonstrated that pasteurized MucT® is more stable and bioavailable than live Akkermansia, which can be degraded by stomach acid before reaching the gut where it needs to work.8* MucT® is the only Akkermansia strain approved by the European Food Safety Authority (EFSA) for use in foods and dietary supplements, a distinction that reflects the depth of the safety and efficacy research behind it.


The Bottom Line

This is where targeted Akkermansia supplementation becomes relevant. The science on Akkermansia and metabolism is still evolving — as it is with most areas of microbiome research — but the body of evidence is substantial and growing. What’s clear is that Akkermansia plays a meaningful role in gut barrier health, metabolic signaling, and weight maintenance, and that maintaining healthy Akkermansia levels is an important piece of the overall metabolic health picture.*

Lemme Metabolism

Lemme Metabolism delivers MucT® pasteurized Akkermansia at 30 Billion AFU — the clinically studied strain, at a meaningful dose, in the form the research supports — alongside Black Ginger Root Extract for visceral fat support9 and Chromium Picolinate for healthy fat metabolism.10* One capsule daily. No refrigeration required.


Frequently Asked Questions

Does Akkermansia help with metabolism?

Research suggests Akkermansia is associated with improved metabolic markers, including insulin function and weight maintenance, though outcomes vary by individual.

Does Akkermansia increase GLP-1?

Preclinical studies suggest Akkermansia may support the body’s natural GLP-1 signaling, though more human research is needed.

What is the best form of Akkermansia?

Pasteurized Akkermansia muciniphila is the most studied form in human clinical trials and is considered more stable than live versions.

How long does Akkermansia take to work?

Because Akkermansia supports metabolic and gut-related pathways, effects are typically gradual. Most research evaluates outcomes over several weeks to months, particularly alongside consistent diet and lifestyle habits.



This article is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting any new supplement regimen.


These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.



References

1. Frontiers in Microbiology. The worldview of Akkermansia muciniphila, a bibliometric analysis. 2025. https://www.frontiersin.org/journals/microbiology/articles/10.3389/fmicb.2025.1500893/full

2. PubMed. Akkermansia muciniphila as a novel powerful bacterial player in the treatment of metabolic disorders. 2022. https://pubmed.ncbi.nlm.nih.gov/35103461/

3. Springer/Microbiome. Antibiotic-associated changes in Akkermansia muciniphila alter its effects on host metabolic health. 2025. https://link.springer.com/article/10.1186/s40168-024-02023-4

4. PMC. The influence of Akkermansia muciniphila on intestinal barrier function. 2024. https://pmc.ncbi.nlm.nih.gov/articles/PMC11297771/

5. PubMed. Akkermansia muciniphila and Gut Immune System: A Good Friendship That Attenuates Inflammatory Bowel Disease, Obesity, and Diabetes. 2022. https://pmc.ncbi.nlm.nih.gov/articles/PMC9300896/

6. PubMed. Revisiting the role of Akkermansia muciniphila as a therapeutic bacterium. 2022. https://pubmed.ncbi.nlm.nih.gov/35613313/

7. PubMed. Akkermansia muciniphila and improved metabolic health during a dietary intervention in obesity. Gut. 2016. https://pubmed.ncbi.nlm.nih.gov/26100928/

8. PubMed. Supplementation with Akkermansia muciniphila in overweight and obese human volunteers: a proof-of-concept exploratory study. Nature Medicine. 2019. https://pubmed.ncbi.nlm.nih.gov/31263284/

9. PMC. Daily intake of Kaempferia parviflora extract decreases abdominal fat in overweight and preobese subjects: a randomized, double-blind, placebo-controlled clinical study. 2018. https://pmc.ncbi.nlm.nih.gov/articles/PMC6120512/

10. PubMed. A scientific review: the role of chromium in insulin resistance. Diabetes Educator. 2004. https://pubmed.ncbi.nlm.nih.gov/15208835/



About the Expert Reviewer

Kathleen Valenton, MD is a board-certified OB/GYN at Rodeo Drive Women’s Health Center in Beverly Hills, CA, with over a decade of experience in women’s health. She completed her internship and residency at Cedars-Sinai Medical Center — where she remains an attending physician — after earning her Medical Degree from the University of Vermont College of Medicine and dual Bachelor’s and Master’s degrees in Psychology from UC Berkeley. Dr. Valenton is also the Chief Medical Officer at Lemme. Her clinical research interests span mental health, hormonal health, infertility, PCOS, and menopause. Dr. Valenton is known for her expertise in pelvic pain, infertility evaluations, and minimally invasive surgery, and remains actively involved in resident education and physician-nursing collaboratives at Cedars-Sinai.

 

¡OHMYGOSHWAGANDHA! ¡OHMYGOSHWAGANDHA! ¡OHMYGOSHWAGANDHA! ¡OHMYGOSHWAGANDHA! ¡OHMYGOSHWAGANDHA! ¡OHMYGOSHWAGANDHA! ¡OHMYGOSHWAGANDHA! ¡OHMYGOSHWAGANDHA! ¡OHMYGOSHWAGANDHA! ¡OHMYGOSHWAGANDHA! ¡OHMYGOSHWAGANDHA! ¡OHMYGOSHWAGANDHA! ¡OHMYGOSHWAGANDHA! ¡OHMYGOSHWAGANDHA! ¡OHMYGOSHWAGANDHA! ¡OHMYGOSHWAGANDHA! ¡OHMYGOSHWAGANDHA! ¡OHMYGOSHWAGANDHA! ¡OHMYGOSHWAGANDHA! ¡OHMYGOSHWAGANDHA!